Jain Global’s Oric Pharmaceuticals ORIC Stock Holding History

Jain Global’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,154	Closed	-$182K	–	1443
2025 Q3	$182K	Buy	+15,154	New	+$159K	﹤0.01%	907

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jain Global's ORIC Position: Q4 2025 in Review

Jain Global sold out of Oric Pharmaceuticals (ORIC) in Q4 2025, closing a stake of 15,154 shares — an estimated $182K sold.

Jain Global first reported a position in ORIC in Q3 2025 and held it in 1 quarter. The position peaked at $182K in Q3 2025. 164 funds tracked by Wall St. Rank hold ORIC as of Q4 2025.

Jain Global reported no remaining Oric Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Jain Global sold 15,154 Oric Pharmaceuticals shares in Q4 2025, an estimated $182K.
Jain Global first reported a position in Oric Pharmaceuticals in Q3 2025 and held it in 1 quarter.
Jain Global's Oric Pharmaceuticals position peaked at $182K in Q3 2025.
164 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.